Inflammation markers associated with COVID-19 during pregnancy may signal adverse impacts to long-term infant health
Being in nature: Good for mind, body and nutrition
25 April 2022Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies
25 April 2022Inflammation markers associated with COVID-19 during pregnancy may signal adverse impacts to long-term infant health
New research results demonstrate how inflammation from a COVID-19 infection during pregnancy could potentially impact long-term infant health, including infant growth and brain development. Published in the Journal of Perinatology, a new study from Boston Medical Center describes how infants of mothers who had a COVID-19 infection during pregnancy had significant elevations in inflammatory blood markers, also known as cytokines, at the time of delivery.
